Otros idiomas BerGenBio ASA

Acciones

En tiempo real Oslo Bors Otros sitios de cotización 12:57:49 27/06/2024			Varia. Cinco días.	Varia. 1 de enero.
11,81 ^NOK	-4,31 %		+9,54 %	-57,53 %

29/05	BerGenBio ASA informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
29/05	Transcript : BerGenBio ASA, Q1 2024 Earnings Call, May 29, 2024

BerGenBio ASA: Grant of share options	26/06
BerGenBio ASA - Registration of reverse share split	03/06
BerGenBio First Quarter Results 2024, Advancing to the Next Stage of Development	30/05
BerGenBio ASA - Ex. reverse share split and change of ISIN today	30/05
BerGenBio ASA, New share capital registered	29/05
BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi	29/05
BerGenBio ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	29/05
BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development	29/05
BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®	28/05
BerGenBio ASA Enter into A Clinical Trial Agreement with the Mays Cancer Center At the University of Texas Health Science Center At San Antonio and Swedish Orphan Biovitrum AB	28/05
BerGenBio ASA - Key information relating to the reverse share split and change of ISIN	28/05
BerGenBio ASA: New share capital registered	28/05
BerGenBio ASA - Minutes from the annual general meeting 2024	23/05
BerGenBio ASA: Invitation to first quarter 2024 results webcast	22/05
BerGenBio ASA: Notice of Annual General Meeting	30/04
BERGENBIO ASA: BOARD APPROVAL OF 2023 ANNUAL FINANCIAL STATEMENT AND ANNUAL REPORT 2023	30/04
BerGenBio ASA: New share capital registered	25/04
BerGenBio ASA: Resolution to increase the share capital for settlement of underwriting commission	17/04
BerGenBio - Disclosure of shareholding	17/04
BerGenBio - Disclosure of large shareholding	17/04

No hay resultados para esta búsqueda